Blar i Brage NMBU på forfatter "Rosness, Anna Hesenget"
-
The mutated BRAF inhibitor vemurafenib and the TRAIL receptor agonist APG350 imply synergistic antitumor effects in melanoma
Rosness, Anna Hesenget (Master thesis, 2013-08-19)Malignant melanoma is one of the most devastating cancer types with aggressive metastasizing abilities and the capability to develop therapy resistance. Until recently, effective therapeutic options have been non-existing, ...